chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diplopia, Dysgeusia, Fatigue, Feeling abnormal
Clinical narrative: very tired; unsteady; weak; felt strange on inside of mouth; upper lip, sinus and eyelid swelling; upper lip, sinus and eyelid swelling; inner nose felt funny; could not read due to double vision; strange metallic taste in mouth; rash all over upper body /blotchy skin on face / neck / upper chest / arms / upper back, pimples on face; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (unsteady), ASTHENIA (weak), FEELING ABNORMAL (felt strange on inside of mouth), LIP SWELLING (upper lip, sinus and eyelid swelling) and SWELLING (upper lip, sinus and eyelid swelling) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy and Allergic reaction to bee sting.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced GAIT DISTURBANCE (unsteady), ASTHENIA (weak), FEELING ABNORMAL (felt strange on inside of mouth), LIP SWELLING (upper lip, sinus and eyelid swelling), SWELLING (upper lip, sinus and eyelid swelling), NASAL DISCOMFORT (inner nose felt funny), DIPLOPIA (could not read due to double vision), DYSGEUSIA (strange metallic taste in mouth) and RASH (rash all over upper body /blotchy skin on face / neck / upper chest / arms / upper back, pimples on face). On 11-Apr-2021, the patient experienced FATIGUE (very tired). On 11-Apr-2021, FATIGUE (very tired) had resolved. On 12-Apr-2021, GAIT DISTURBANCE (unsteady), ASTHENIA (weak), FEELING ABNORMAL (felt strange on inside of mouth), LIP SWELLING (upper lip, sinus and eyelid swelling), SWELLING (upper lip, sinus and eyelid swelling), NASAL DISCOMFORT (inner nose felt funny), DIPLOPIA (could not read due to double vision), DYSGEUSIA (strange metallic taste in mouth) and RASH (rash all over upper body /blotchy skin on face / neck / upper chest / arms / upper back, pimples on face) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  The patient reported that she was getting better. She wanted to know if there is a blood test to check if she has the immunity and if she could get the second dose if she takes an EpiPen (epinephrine) with her.  No treatment information was reported.  Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded. Additional information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded. Additional information has been requested.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Lip swelling, Nasal discomfort, Rash, Swelling
Clinical narrative: very tired; unsteady; weak; felt strange on inside of mouth; upper lip, sinus and eyelid swelling; upper lip, sinus and eyelid swelling; inner nose felt funny; could not read due to double vision; strange metallic taste in mouth; rash all over upper body /blotchy skin on face / neck / upper chest / arms / upper back, pimples on face; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (unsteady), ASTHENIA (weak), FEELING ABNORMAL (felt strange on inside of mouth), LIP SWELLING (upper lip, sinus and eyelid swelling) and SWELLING (upper lip, sinus and eyelid swelling) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy and Allergic reaction to bee sting.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced GAIT DISTURBANCE (unsteady), ASTHENIA (weak), FEELING ABNORMAL (felt strange on inside of mouth), LIP SWELLING (upper lip, sinus and eyelid swelling), SWELLING (upper lip, sinus and eyelid swelling), NASAL DISCOMFORT (inner nose felt funny), DIPLOPIA (could not read due to double vision), DYSGEUSIA (strange metallic taste in mouth) and RASH (rash all over upper body /blotchy skin on face / neck / upper chest / arms / upper back, pimples on face). On 11-Apr-2021, the patient experienced FATIGUE (very tired). On 11-Apr-2021, FATIGUE (very tired) had resolved. On 12-Apr-2021, GAIT DISTURBANCE (unsteady), ASTHENIA (weak), FEELING ABNORMAL (felt strange on inside of mouth), LIP SWELLING (upper lip, sinus and eyelid swelling), SWELLING (upper lip, sinus and eyelid swelling), NASAL DISCOMFORT (inner nose felt funny), DIPLOPIA (could not read due to double vision), DYSGEUSIA (strange metallic taste in mouth) and RASH (rash all over upper body /blotchy skin on face / neck / upper chest / arms / upper back, pimples on face) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  The patient reported that she was getting better. She wanted to know if there is a blood test to check if she has the immunity and if she could get the second dose if she takes an EpiPen (epinephrine) with her.  No treatment information was reported.  Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded. Additional information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded. Additional information has been requested.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema
Clinical narrative: Pain from her elbow to her wrist; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain from her elbow to her wrist) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain from her elbow to her wrist) and VACCINATION SITE ERYTHEMA (Redness at the injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain from her elbow to her wrist) and VACCINATION SITE ERYTHEMA (Redness at the injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Email address was updated, all event outcome was updated from unknown to recovered.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm/arm is still sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm/arm is still sore) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm/arm is still sore). At the time of the report, PAIN IN EXTREMITY (sore arm/arm is still sore) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable. Treatment medicines  included Bengay ,Tylenol  and rubbing alcohol at injection site.   Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: Follow up received on 12 April 2021 and updated patient demographics and  event.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness of the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of the arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness of the arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 21-Feb-2021, PAIN IN EXTREMITY (Soreness of the arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to INC.-MOD-2021-073916 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: The follow up received on 24 May 2021 contains information which not in a readable format; Sender's Comments: INC.-MOD-2021-073916:Dose 2
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Tested positive; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive). At the time of the report, COVID-19 (Tested positive) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-073799 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-073799:Husband Case
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Heart rate, Tenderness
Clinical narrative: slightly tender arm; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (slightly tender arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 039K20A) for COVID-19 vaccination.     The patient's past medical history included Asthma chronic (Worsened after 1st COVID vaccine) since an unknown date. Concurrent medical conditions included Pollen allergy and Drug allergy (sulfa). Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.   On 08-Jan-2021 at 3:24 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021 at 11:10 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TENDERNESS (slightly tender arm). At the time of the report, TENDERNESS (slightly tender arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, Blood pressure measurement: (Inconclusive) result not mentioned. On 08-Jan-2021, Heart rate: 100-115 for a period of 2 hours.         Patient took concomitant drug Zyrtec once prior to her second vaccine. No treatment information was provided.  Event occurred after the second vaccine administration.  Action taken with mRNA-1273 in response to the event was not applicable.; Sender's Comments:
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Invalid age of 17; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Invalid age of 17) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Invalid age of 17). On 06-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Invalid age of 17) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were provided.  Patient did not experience any adverse event.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: New reporter information. Updated Patient demographics. Second dose details updated.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chest X-ray, Chills, Dyspnoea, Fatigue
Clinical narrative: Something going on with the thyroid; High blood pressure; Out of breath/Was winded; Couldn't walk hardly; Severe muscle aches; Became exhausted/Extremely tired/No stamina; Severe chills; Severe headache; lethargic; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Out of breath/Was winded), HYPERTENSION (High blood pressure), THYROID DISORDER (Something going on with the thyroid), GAIT DISTURBANCE (Couldn't walk hardly) and LETHARGY (lethargic) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMINS NOS for an unknown indication.    On 20-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced LETHARGY (lethargic). On 21-Mar-2021, the patient experienced DYSPNOEA (Out of breath/Was winded), GAIT DISTURBANCE (Couldn't walk hardly), MYALGIA (Severe muscle aches), FATIGUE (Became exhausted/Extremely tired/No stamina), CHILLS (Severe chills) and HEADACHE (Severe headache). On 08-Apr-2021, the patient experienced HYPERTENSION (High blood pressure). On an unknown date, the patient experienced THYROID DISORDER (Something going on with the thyroid). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Out of breath/Was winded), GAIT DISTURBANCE (Couldn't walk hardly), LETHARGY (lethargic), MYALGIA (Severe muscle aches), CHILLS (Severe chills) and HEADACHE (Severe headache) outcome was unknown and HYPERTENSION (High blood pressure), THYROID DISORDER (Something going on with the thyroid) and FATIGUE (Became exhausted/Extremely tired/No stamina) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Blood pressure measurement (128-64): 168/86 (High) 168/86. On 19-May-2021, Chest X-ray: Inconclusive.         This case was linked to US-MODERNATX, INC.-MOD-2021-073911 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow-up received.ADR Form in which patient's demographic details , event details were updated; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-073911:Dose 1
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Headache, Hypertension, Lethargy, Myalgia
Clinical narrative: Something going on with the thyroid; High blood pressure; Out of breath/Was winded; Couldn't walk hardly; Severe muscle aches; Became exhausted/Extremely tired/No stamina; Severe chills; Severe headache; lethargic; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Out of breath/Was winded), HYPERTENSION (High blood pressure), THYROID DISORDER (Something going on with the thyroid), GAIT DISTURBANCE (Couldn't walk hardly) and LETHARGY (lethargic) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMINS NOS for an unknown indication.    On 20-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced LETHARGY (lethargic). On 21-Mar-2021, the patient experienced DYSPNOEA (Out of breath/Was winded), GAIT DISTURBANCE (Couldn't walk hardly), MYALGIA (Severe muscle aches), FATIGUE (Became exhausted/Extremely tired/No stamina), CHILLS (Severe chills) and HEADACHE (Severe headache). On 08-Apr-2021, the patient experienced HYPERTENSION (High blood pressure). On an unknown date, the patient experienced THYROID DISORDER (Something going on with the thyroid). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Out of breath/Was winded), GAIT DISTURBANCE (Couldn't walk hardly), LETHARGY (lethargic), MYALGIA (Severe muscle aches), CHILLS (Severe chills) and HEADACHE (Severe headache) outcome was unknown and HYPERTENSION (High blood pressure), THYROID DISORDER (Something going on with the thyroid) and FATIGUE (Became exhausted/Extremely tired/No stamina) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Blood pressure measurement (128-64): 168/86 (High) 168/86. On 19-May-2021, Chest X-ray: Inconclusive.         This case was linked to US-MODERNATX, INC.-MOD-2021-073911 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow-up received.ADR Form in which patient's demographic details , event details were updated; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-073911:Dose 1
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Thyroid disorder
Clinical narrative: Something going on with the thyroid; High blood pressure; Out of breath/Was winded; Couldn't walk hardly; Severe muscle aches; Became exhausted/Extremely tired/No stamina; Severe chills; Severe headache; lethargic; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Out of breath/Was winded), HYPERTENSION (High blood pressure), THYROID DISORDER (Something going on with the thyroid), GAIT DISTURBANCE (Couldn't walk hardly) and LETHARGY (lethargic) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMINS NOS for an unknown indication.    On 20-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced LETHARGY (lethargic). On 21-Mar-2021, the patient experienced DYSPNOEA (Out of breath/Was winded), GAIT DISTURBANCE (Couldn't walk hardly), MYALGIA (Severe muscle aches), FATIGUE (Became exhausted/Extremely tired/No stamina), CHILLS (Severe chills) and HEADACHE (Severe headache). On 08-Apr-2021, the patient experienced HYPERTENSION (High blood pressure). On an unknown date, the patient experienced THYROID DISORDER (Something going on with the thyroid). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Out of breath/Was winded), GAIT DISTURBANCE (Couldn't walk hardly), LETHARGY (lethargic), MYALGIA (Severe muscle aches), CHILLS (Severe chills) and HEADACHE (Severe headache) outcome was unknown and HYPERTENSION (High blood pressure), THYROID DISORDER (Something going on with the thyroid) and FATIGUE (Became exhausted/Extremely tired/No stamina) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Blood pressure measurement (128-64): 168/86 (High) 168/86. On 19-May-2021, Chest X-ray: Inconclusive.         This case was linked to US-MODERNATX, INC.-MOD-2021-073911 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow-up received.ADR Form in which patient's demographic details , event details were updated; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-073911:Dose 1
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: itchy arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy arm). On 16-Mar-2021, VACCINATION SITE PRURITUS (itchy arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-073926 (Patient Link).
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: inadvertently administered with 1.0 ml of the vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (inadvertently administered with 1.0 ml of the vaccine) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Medical history reported).    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced ACCIDENTAL OVERDOSE (inadvertently administered with 1.0 ml of the vaccine). On 10-Apr-2021, ACCIDENTAL OVERDOSE (inadvertently administered with 1.0 ml of the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information provided. No adverse reactions have been reported so far.; Sender's Comments: This report refers to a case of patient inadvertently administrated with1.0 ml of the vaccine for mRNA 1273, Lot # 016B21A with no associated AEs. Causality for the medication error is not applicable.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Fatigue
Clinical narrative: Really bad diarrhea; Loss of appetite/did not eat for 2 days; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Really bad diarrhea), DECREASED APPETITE (Loss of appetite/did not eat for 2 days) and FATIGUE (Fatigue) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diarrhoea and Acid reflux (esophageal). Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), ACETYLSALICYLIC ACID (ASPIRIN 81), VITAMIN D NOS, CARVEDILOL, IRON, METFORMIN, LOSARTAN and ATORVASTATIN for an unknown indication.    On 09-Apr-2021 at 1:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced DECREASED APPETITE (Loss of appetite/did not eat for 2 days) and FATIGUE (Fatigue). On 10-Apr-2021, the patient experienced DIARRHOEA (Really bad diarrhea). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE]) at an unspecified dose and frequency. On 11-Apr-2021, DIARRHOEA (Really bad diarrhea) had resolved. At the time of the report, DECREASED APPETITE (Loss of appetite/did not eat for 2 days) was resolving and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Carbon dioxide, Chills, Cough, Diarrhoea
Clinical narrative: diarrhea; vomiting; Coughing; nose running; flu-like symptoms; shaking chills; headache; aches; feverish; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), RHINORRHOEA (nose running), DIARRHOEA (diarrhea), COUGH (Coughing) and CHILLS (shaking chills) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), HEADACHE (headache) and MYALGIA (aches). 08-Apr-2021, the patient experienced CHILLS (shaking chills) and PYREXIA (feverish). On 09-Apr-2021, the patient experienced RHINORRHOEA (nose running) and COUGH (Coughing). On 12-Apr-2021, the patient experienced DIARRHOEA (diarrhea) and VOMITING (vomiting). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), RHINORRHOEA (nose running), DIARRHOEA (diarrhea), COUGH (Coughing), CHILLS (shaking chills), VOMITING (vomiting), HEADACHE (headache), MYALGIA (aches) and PYREXIA (feverish) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Body temperature: 99.5 (Inconclusive) low-grade fever of 99.5 degrees F. On 10-Apr-2021, Carbon dioxide:. On 24-Apr-2021, Carbon dioxide: 93 (Inconclusive) CO2 93.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Myalgia, Pyrexia, Rhinorrhoea
Clinical narrative: diarrhea; vomiting; Coughing; nose running; flu-like symptoms; shaking chills; headache; aches; feverish; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), RHINORRHOEA (nose running), DIARRHOEA (diarrhea), COUGH (Coughing) and CHILLS (shaking chills) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), HEADACHE (headache) and MYALGIA (aches). 08-Apr-2021, the patient experienced CHILLS (shaking chills) and PYREXIA (feverish). On 09-Apr-2021, the patient experienced RHINORRHOEA (nose running) and COUGH (Coughing). On 12-Apr-2021, the patient experienced DIARRHOEA (diarrhea) and VOMITING (vomiting). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), RHINORRHOEA (nose running), DIARRHOEA (diarrhea), COUGH (Coughing), CHILLS (shaking chills), VOMITING (vomiting), HEADACHE (headache), MYALGIA (aches) and PYREXIA (feverish) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Body temperature: 99.5 (Inconclusive) low-grade fever of 99.5 degrees F. On 10-Apr-2021, Carbon dioxide:. On 24-Apr-2021, Carbon dioxide: 93 (Inconclusive) CO2 93.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: diarrhea; vomiting; Coughing; nose running; flu-like symptoms; shaking chills; headache; aches; feverish; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), RHINORRHOEA (nose running), DIARRHOEA (diarrhea), COUGH (Coughing) and CHILLS (shaking chills) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), HEADACHE (headache) and MYALGIA (aches). 08-Apr-2021, the patient experienced CHILLS (shaking chills) and PYREXIA (feverish). On 09-Apr-2021, the patient experienced RHINORRHOEA (nose running) and COUGH (Coughing). On 12-Apr-2021, the patient experienced DIARRHOEA (diarrhea) and VOMITING (vomiting). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), RHINORRHOEA (nose running), DIARRHOEA (diarrhea), COUGH (Coughing), CHILLS (shaking chills), VOMITING (vomiting), HEADACHE (headache), MYALGIA (aches) and PYREXIA (feverish) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Body temperature: 99.5 (Inconclusive) low-grade fever of 99.5 degrees F. On 10-Apr-2021, Carbon dioxide:. On 24-Apr-2021, Carbon dioxide: 93 (Inconclusive) CO2 93.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Hypersensitivity, Influenza like illness, Pyrexia
Clinical narrative: allergy symptoms; moderate flu symptoms; congestion in head; sinus symptoms; didn't feel like doing anything all day long; fever, temperature of 101; a little bit of chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergy symptoms), INFLUENZA LIKE ILLNESS (moderate flu symptoms), SINUS CONGESTION (congestion in head), SINUS DISORDER (sinus symptoms) and FEELING ABNORMAL (didn't feel like doing anything all day long) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C211A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.).    On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced HYPERSENSITIVITY (allergy symptoms), INFLUENZA LIKE ILLNESS (moderate flu symptoms), SINUS CONGESTION (congestion in head), SINUS DISORDER (sinus symptoms), FEELING ABNORMAL (didn't feel like doing anything all day long), PYREXIA (fever, temperature of 101) and CHILLS (a little bit of chills). At the time of the report, HYPERSENSITIVITY (allergy symptoms), INFLUENZA LIKE ILLNESS (moderate flu symptoms), SINUS CONGESTION (congestion in head), SINUS DISORDER (sinus symptoms), FEELING ABNORMAL (didn't feel like doing anything all day long), PYREXIA (fever, temperature of 101) and CHILLS (a little bit of chills) was resolving.            Treatment included cetirizine.
Sex: M
Vaccine: COVID19
Symptoms: Sinus congestion, Sinus disorder
Clinical narrative: allergy symptoms; moderate flu symptoms; congestion in head; sinus symptoms; didn't feel like doing anything all day long; fever, temperature of 101; a little bit of chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergy symptoms), INFLUENZA LIKE ILLNESS (moderate flu symptoms), SINUS CONGESTION (congestion in head), SINUS DISORDER (sinus symptoms) and FEELING ABNORMAL (didn't feel like doing anything all day long) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C211A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.).    On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced HYPERSENSITIVITY (allergy symptoms), INFLUENZA LIKE ILLNESS (moderate flu symptoms), SINUS CONGESTION (congestion in head), SINUS DISORDER (sinus symptoms), FEELING ABNORMAL (didn't feel like doing anything all day long), PYREXIA (fever, temperature of 101) and CHILLS (a little bit of chills). At the time of the report, HYPERSENSITIVITY (allergy symptoms), INFLUENZA LIKE ILLNESS (moderate flu symptoms), SINUS CONGESTION (congestion in head), SINUS DISORDER (sinus symptoms), FEELING ABNORMAL (didn't feel like doing anything all day long), PYREXIA (fever, temperature of 101) and CHILLS (a little bit of chills) was resolving.            Treatment included cetirizine.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Burning sensation, Joint noise, Symptom recurrence
Clinical narrative: tumor markers elevated after first dose; burning shoulder and arms; both arms have a burning sensation, was felt in jaw and face; joints popping throughout body; symptoms traveling to different parts of the body; very weak, can't push up off the floor; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (both arms have a burning sensation, was felt in jaw and face), JOINT NOISE (joints popping throughout body), SYMPTOM RECURRENCE (symptoms traveling to different parts of the body), ASTHENIA (very weak, can't push up off the floor) and TUMOUR MARKER INCREASED (tumor markers elevated after first dose) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer NOS stage IV since an unknown date and White blood cell count low (low while blood count due to stage4 breast cancer.) since an unknown date.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced BURNING SENSATION (both arms have a burning sensation, was felt in jaw and face), JOINT NOISE (joints popping throughout body), SYMPTOM RECURRENCE (symptoms traveling to different parts of the body), ASTHENIA (very weak, can't push up off the floor) and ARTHRALGIA (burning shoulder and arms). On an unknown date, the patient experienced TUMOUR MARKER INCREASED (tumor markers elevated after first dose). At the time of the report, BURNING SENSATION (both arms have a burning sensation, was felt in jaw and face), JOINT NOISE (joints popping throughout body), SYMPTOM RECURRENCE (symptoms traveling to different parts of the body), ASTHENIA (very weak, can't push up off the floor), TUMOUR MARKER INCREASED (tumor markers elevated after first dose) and ARTHRALGIA (burning shoulder and arms) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Thyroxine free: 1.54 her freeT4 was at 1.54. In March 2021, Tumour marker increased: 48.4 (High) Her CA27-29 are at 48.4 range, markers went up after the vaccine and are now outside of normal range, where they had been.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient is on medications for her breast cancer. No treatment medications were provided
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Thyroxine free, Tumour marker increased
Clinical narrative: tumor markers elevated after first dose; burning shoulder and arms; both arms have a burning sensation, was felt in jaw and face; joints popping throughout body; symptoms traveling to different parts of the body; very weak, can't push up off the floor; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (both arms have a burning sensation, was felt in jaw and face), JOINT NOISE (joints popping throughout body), SYMPTOM RECURRENCE (symptoms traveling to different parts of the body), ASTHENIA (very weak, can't push up off the floor) and TUMOUR MARKER INCREASED (tumor markers elevated after first dose) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer NOS stage IV since an unknown date and White blood cell count low (low while blood count due to stage4 breast cancer.) since an unknown date.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced BURNING SENSATION (both arms have a burning sensation, was felt in jaw and face), JOINT NOISE (joints popping throughout body), SYMPTOM RECURRENCE (symptoms traveling to different parts of the body), ASTHENIA (very weak, can't push up off the floor) and ARTHRALGIA (burning shoulder and arms). On an unknown date, the patient experienced TUMOUR MARKER INCREASED (tumor markers elevated after first dose). At the time of the report, BURNING SENSATION (both arms have a burning sensation, was felt in jaw and face), JOINT NOISE (joints popping throughout body), SYMPTOM RECURRENCE (symptoms traveling to different parts of the body), ASTHENIA (very weak, can't push up off the floor), TUMOUR MARKER INCREASED (tumor markers elevated after first dose) and ARTHRALGIA (burning shoulder and arms) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Thyroxine free: 1.54 her freeT4 was at 1.54. In March 2021, Tumour marker increased: 48.4 (High) Her CA27-29 are at 48.4 range, markers went up after the vaccine and are now outside of normal range, where they had been.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient is on medications for her breast cancer. No treatment medications were provided
Sex: F
Vaccine: COVID19
Symptoms: Amnesia
Clinical narrative: Short term memory loss; This spontaneous case was reported by a consumer and describes the occurrence of AMNESIA (Short term memory loss) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AMNESIA (Short term memory loss). At the time of the report, AMNESIA (Short term memory loss) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the events was not applicable.  Concomitant medications were not provided.  Treatment information was not provided.   Reporter did not allow further contact
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Myalgia, Vaccination site erythema
Clinical narrative: unable to sleep; arm pain; redness around injection; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (unable to sleep), MYALGIA (arm pain) and VACCINATION SITE ERYTHEMA (redness around injection) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 048A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced INSOMNIA (unable to sleep), MYALGIA (arm pain) and VACCINATION SITE ERYTHEMA (redness around injection). On 10-Apr-2021, INSOMNIA (unable to sleep) had resolved. At the time of the report, MYALGIA (arm pain) and VACCINATION SITE ERYTHEMA (redness around injection) outcome was unknown.            No concomitant medications or treatment medications were provided
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest discomfort, Cough, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Having symptoms of COVID-19; Heavy chest breathing; sore throat; cough; runny nose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Having symptoms of COVID-19), CHEST DISCOMFORT (Heavy chest breathing), OROPHARYNGEAL PAIN (sore throat), COUGH (cough) and RHINORRHOEA (runny nose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Having symptoms of COVID-19), CHEST DISCOMFORT (Heavy chest breathing), OROPHARYNGEAL PAIN (sore throat), COUGH (cough) and RHINORRHOEA (runny nose). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, COVID-19 (Having symptoms of COVID-19), CHEST DISCOMFORT (Heavy chest breathing), OROPHARYNGEAL PAIN (sore throat), COUGH (cough) and RHINORRHOEA (runny nose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Gastrooesophageal reflux disease, Peripheral swelling, Pyrexia
Clinical narrative: GERD was amplified; arm was swollen; fever; chills; tired; arm was swollen and red; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE, PERIPHERAL SWELLING, PYREXIA, CHILLS, and FATIGUE in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cervical dystonia, Tremor and GERD.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE, PERIPHERAL SWELLING, PYREXIA, CHILLS, FATIGUE, and VACCINATION SITE ERYTHEMA. The patient was treated with TYLENOL for Symptomatic treatment, at an unspecified dose and frequency. On 13-Mar-2021, GASTROOESOPHAGEAL REFLUX DISEASE, PERIPHERAL SWELLING, PYREXIA, CHILLS, FATIGUE, and VACCINATION SITE ERYTHEMA had resolved.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  The patient called the Pharmacist to see if she should go to urgent care or ER, who suggested the events were just side effects of the vaccine. Concomitant medications were not provided. Treatment also included Theraflu and stated that she treated it like a flu   This case was linked to US-MODERNATX, INC-MOD-2021-073937. Sender's Comments:  US-MODERNATX, INC-MOD-2021-073937: Second dose.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: GERD was amplified; arm was swollen; fever; chills; tired; arm was swollen and red; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE, PERIPHERAL SWELLING, PYREXIA, CHILLS, and FATIGUE in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cervical dystonia, Tremor and GERD.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE, PERIPHERAL SWELLING, PYREXIA, CHILLS, FATIGUE, and VACCINATION SITE ERYTHEMA. The patient was treated with TYLENOL for Symptomatic treatment, at an unspecified dose and frequency. On 13-Mar-2021, GASTROOESOPHAGEAL REFLUX DISEASE, PERIPHERAL SWELLING, PYREXIA, CHILLS, FATIGUE, and VACCINATION SITE ERYTHEMA had resolved.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  The patient called the Pharmacist to see if she should go to urgent care or ER, who suggested the events were just side effects of the vaccine. Concomitant medications were not provided. Treatment also included Theraflu and stated that she treated it like a flu   This case was linked to US-MODERNATX, INC-MOD-2021-073937. Sender's Comments:  US-MODERNATX, INC-MOD-2021-073937: Second dose.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Ocular hyperaemia
Clinical narrative: eye redness; Sore arm; tired; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR HYPERAEMIA (eye redness), MYALGIA (Sore arm) and FATIGUE (tired) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information reported.  Concomitant products included NAPROXEN SODIUM (ALEVE) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OCULAR HYPERAEMIA (eye redness), MYALGIA (Sore arm) and FATIGUE (tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, OCULAR HYPERAEMIA (eye redness), MYALGIA (Sore arm) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.